(814) 860-3179 
Have previous antidepressant treatments failed to mitigate your major depressive disorder (MDD)? If you've tried two or more without success, you may eligible for Spravato™, an esketamine nasal spray that is taken in combination with an oral antidepressant.
Because of the risk of sedation and/or dissociation, patients receiving esketamine nasal spray must remain under professional supervision for at least two hours after administration of each dose. You must arrange for transportation from the office after receiving Spravato™, as the operation of vehicles or heavy machinery is inadvisable.
Esketamine Therapy Benefits
- FDA approved for treatment-resistant MDD with co-occurring suicidal ideation/behavior
- Patients in stable remission or with stable response demonstrated significantly longer periods between depressive episodes
- Recipients are closely monitored and cared for by our highly qualified staff.
Providers
Joshua Neal, Psychiatric Mental Health Nurse Practitioner
Psychiatry
I am originally from Erie, PA, and graduated from McDowell High School in 2007. After high school, I obtained undergraduate degrees from the University of North Carolina at Charlotte and Samford University in Birmingham, AL. I attended East Tennessee State for my graduate degree. For part of my training, I secured ... Read More
UPMCSend Us a Message
